Centenarian and PSA life member JSD ‘Stan’ Mellick OAM, ED, PhC, BA, PhD reflects on a 75-year association with pharmacy.

The Therapeutic Goods Administration (TGA) has delivered an interim decision to down-schedule low dose cannabidiol.

Antibiotic use has crept back up since COVID-19 restrictions have lifted, with multi-resistant bugs increasingly in our midst.

Patients are being harmed because we are not talking about the adverse effects of mental health medicines.

The PSA has provided a blueprint to help Federal Treasurer Jim Chalmers improve primary care and enhance medicine safety for all Australians.

Rather than managing adverse events after the fact, the ACTmed trial helps pharmacists tackle medicine-related problems before they arise.